Antisense Therapeutics (ASX:ANP) closes in on clinical supplies for muscular dystrophy trial
- Antisense Therapeutics (ANP) has moved a step closer towards manufacturing the first batch of clinical supplies for its muscular dystrophy treatment clinical trial
- Through its North American supply chain, the ASX-lister has been able to formulate ATL1102's active pharmaceutical ingredient, API, into an injectable product for use in clinical trials
- The product is currently undergoing finished product release testing for clinical use, with results anticipated next month according to ANP
- The drug is hoped to aid non-ambulant Duchenne muscular dystrophy patients by targeting inflammation that aggravates muscle fibre damage
- Antisense Therapeutics shares are up five per cent following the announcement, trading at 21 cents
http://themarketherald.com.au/antisense-therapeutics-asxanp-closes-in-on-clinical-supplies-for-muscular-dystrophy-trial-2021-05-26/?utm_source=threadview%20tmh%20widget&utm_medium=widget&utm_campaign=threadview%20tmh%20widget%20%7C%20click&utm_content=https://hotcopper.com.au/threads/widely-fully-financed-companies.5271206/page-18#post-53416677&utm_term=blank
- Forums
- ASX - By Stock
- PER
- Where others have failed will Atl1102 succeed ?
Where others have failed will Atl1102 succeed ?, page-199
-
- There are more pages in this discussion • 898 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add PER (ASX) to my watchlist
(20min delay)
|
|||||
Last
13.5¢ |
Change
0.000(0.00%) |
Mkt cap ! $121.7M |
Open | High | Low | Value | Volume |
0.0¢ | 0.0¢ | 0.0¢ | $0 | 0 |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
1 | 35714 | 14.0¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
9.8¢ | 37037 | 1 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
1 | 35714 | 0.140 |
1 | 15269 | 0.135 |
2 | 39666 | 0.130 |
4 | 42475 | 0.120 |
3 | 1044892 | 0.115 |
Price($) | Vol. | No. |
---|---|---|
0.098 | 37037 | 1 |
0.100 | 625000 | 3 |
0.105 | 102000 | 1 |
0.110 | 350000 | 2 |
0.115 | 535000 | 2 |
Last trade - 16.12pm 17/10/2024 (20 minute delay) ? |
Featured News
PER (ASX) Chart |
Day chart unavailable
The Watchlist
LPM
LITHIUM PLUS MINERALS LTD.
Simon Kidston, Non Executive Director
Simon Kidston
Non Executive Director
SPONSORED BY The Market Online